Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0002 Transporter Info | ||||
Gene Name | ABCC2 | ||||
Transporter Name | Multidrug resistance-associated protein 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg10264188) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.32E-07; Z-score: 1.27E+00 | ||
Methylation in Case |
5.65E-01 (Median) | Methylation in Control | 5.00E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg09177518) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.22E+00 | Statistic Test | p-value: 4.10E-24; Z-score: 4.91E+00 | ||
Methylation in Case |
2.67E-01 (Median) | Methylation in Control | 8.30E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg14208112) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.63E+00 | Statistic Test | p-value: 3.05E-17; Z-score: 3.28E+00 | ||
Methylation in Case |
1.14E-01 (Median) | Methylation in Control | 7.02E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg15623519) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 6.60E-07; Z-score: -2.16E+00 | ||
Methylation in Case |
2.83E-01 (Median) | Methylation in Control | 3.69E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg06210630) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.52E-04; Z-score: -7.42E-01 | ||
Methylation in Case |
5.45E-01 (Median) | Methylation in Control | 5.71E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg21378238) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 3.61E-03; Z-score: 1.86E-01 | ||
Methylation in Case |
2.97E-01 (Median) | Methylation in Control | 2.87E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
1stExon (cg24173049) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.52E+00 | Statistic Test | p-value: 5.09E-05; Z-score: -1.22E+00 | ||
Methylation in Case |
1.14E-01 (Median) | Methylation in Control | 2.88E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg09283154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.87E+00 | Statistic Test | p-value: 8.12E-16; Z-score: 2.76E+00 | ||
Methylation in Case |
3.94E-01 (Median) | Methylation in Control | 2.10E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg15889012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 6.34E-08; Z-score: -2.06E+00 | ||
Methylation in Case |
1.61E-01 (Median) | Methylation in Control | 2.21E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg11201401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 7.04E-04; Z-score: 7.93E-01 | ||
Methylation in Case |
5.28E-01 (Median) | Methylation in Control | 4.78E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of ABCC2 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg11805188) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.70E-02; Z-score: 7.94E-01 | ||
Methylation in Case |
4.88E-01 (Median) | Methylation in Control | 4.30E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg05914069) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.00E-03; Z-score: -2.28E+00 | ||
Methylation in Case |
7.39E-01 (Median) | Methylation in Control | 7.83E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg09448875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 1.24E-05; Z-score: -2.28E+01 | ||
Methylation in Case |
6.29E-01 (Median) | Methylation in Control | 8.27E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg17044311) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.92E+00 | Statistic Test | p-value: 3.57E-13; Z-score: -1.45E+01 | ||
Methylation in Case |
4.06E-01 (Median) | Methylation in Control | 7.78E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg13617376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.77E+00 | Statistic Test | p-value: 2.90E-11; Z-score: -1.73E+01 | ||
Methylation in Case |
4.73E-01 (Median) | Methylation in Control | 8.38E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg02672229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.88E+00 | Statistic Test | p-value: 1.09E-08; Z-score: -2.14E+01 | ||
Methylation in Case |
4.49E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg00706648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.61E-06; Z-score: -7.42E+00 | ||
Methylation in Case |
7.31E-01 (Median) | Methylation in Control | 7.94E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14303526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.40E-04; Z-score: -2.97E+00 | ||
Methylation in Case |
7.31E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg05916255) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.41E-02; Z-score: -1.95E+00 | ||
Methylation in Case |
7.40E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg08720365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.42E-02; Z-score: -6.97E-01 | ||
Methylation in Case |
7.62E-01 (Median) | Methylation in Control | 7.80E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of ABCC2 in bladder cancer | [ 2 ] | |||
Location |
3'UTR (cg10841077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 8.61E-03; Z-score: -2.36E+00 | ||
Methylation in Case |
8.94E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg00826767) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 3.34E-07; Z-score: -1.85E+00 | ||
Methylation in Case |
7.28E-01 (Median) | Methylation in Control | 7.89E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg09448875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 2.55E-08; Z-score: -2.20E+00 | ||
Methylation in Case |
6.99E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg00706648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 3.52E-10; Z-score: -2.13E+00 | ||
Methylation in Case |
7.26E-01 (Median) | Methylation in Control | 7.85E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg14303526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 1.28E-07; Z-score: -1.52E+00 | ||
Methylation in Case |
6.53E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg19378330) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.33E+00 | Statistic Test | p-value: 4.65E-07; Z-score: 1.65E+00 | ||
Methylation in Case |
9.35E-02 (Median) | Methylation in Control | 4.01E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg02672229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 3.30E-05; Z-score: -1.28E+00 | ||
Methylation in Case |
7.06E-01 (Median) | Methylation in Control | 8.23E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg12673726) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.38E+00 | Statistic Test | p-value: 5.66E-05; Z-score: 1.06E+00 | ||
Methylation in Case |
5.37E-02 (Median) | Methylation in Control | 3.89E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg25290633) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 9.35E-05; Z-score: -8.82E-01 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg05916255) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 9.11E-04; Z-score: -7.14E-01 | ||
Methylation in Case |
7.52E-01 (Median) | Methylation in Control | 8.38E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg16201095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.02E-03; Z-score: -4.81E-01 | ||
Methylation in Case |
9.58E-01 (Median) | Methylation in Control | 9.68E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
Body (cg17044311) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.43E-02; Z-score: -7.52E-01 | ||
Methylation in Case |
7.89E-01 (Median) | Methylation in Control | 8.34E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of ABCC2 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg10841077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.75E-03; Z-score: -5.33E-01 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg00826767) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.40E-05; Z-score: -9.89E-01 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg16377144) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.26E-05; Z-score: -1.18E+00 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 9.24E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg05914069) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.54E-04; Z-score: -7.53E-01 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 9.05E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg00706648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 8.51E-12; Z-score: -2.74E+00 | ||
Methylation in Case |
7.66E-01 (Median) | Methylation in Control | 8.18E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg02672229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.68E-09; Z-score: -2.86E+00 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 9.04E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg17044311) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 3.35E-09; Z-score: -3.22E+00 | ||
Methylation in Case |
8.61E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg13617376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 6.36E-08; Z-score: -1.99E+00 | ||
Methylation in Case |
8.56E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg19604369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 6.49E-06; Z-score: -1.11E+00 | ||
Methylation in Case |
9.16E-01 (Median) | Methylation in Control | 9.27E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg19378330) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 1.64E-04; Z-score: 3.41E-01 | ||
Methylation in Case |
1.28E-01 (Median) | Methylation in Control | 1.08E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg12673726) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 4.10E-03; Z-score: -1.58E-01 | ||
Methylation in Case |
1.02E-01 (Median) | Methylation in Control | 1.12E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg05916255) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.33E-02; Z-score: -1.50E+00 | ||
Methylation in Case |
8.75E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of ABCC2 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg07520093) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 2.73E-02; Z-score: -2.90E-01 | ||
Methylation in Case |
7.10E-02 (Median) | Methylation in Control | 7.62E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg05914069) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.26E-03; Z-score: -4.21E-01 | ||
Methylation in Case |
7.48E-01 (Median) | Methylation in Control | 7.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg14645545) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.09E+00 | Statistic Test | p-value: 1.52E-18; Z-score: 3.28E+00 | ||
Methylation in Case |
4.51E-01 (Median) | Methylation in Control | 2.16E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg19708984) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.20E+00 | Statistic Test | p-value: 2.19E-18; Z-score: -4.26E+00 | ||
Methylation in Case |
3.12E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg10333311) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 7.44E-14; Z-score: -4.94E+00 | ||
Methylation in Case |
5.00E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg04558907) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.49E+00 | Statistic Test | p-value: 5.18E-13; Z-score: -3.81E+00 | ||
Methylation in Case |
4.96E-01 (Median) | Methylation in Control | 7.41E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg19715414) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.08E+00 | Statistic Test | p-value: 1.82E-11; Z-score: 3.10E+00 | ||
Methylation in Case |
3.47E-01 (Median) | Methylation in Control | 1.67E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg13617376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 2.29E-09; Z-score: -1.42E+00 | ||
Methylation in Case |
4.54E-01 (Median) | Methylation in Control | 6.15E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg12673726) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.48E+00 | Statistic Test | p-value: 5.80E-08; Z-score: 1.72E+00 | ||
Methylation in Case |
4.31E-01 (Median) | Methylation in Control | 2.91E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg16201095) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.75E-07; Z-score: -1.24E+00 | ||
Methylation in Case |
9.38E-01 (Median) | Methylation in Control | 9.57E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg14303526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 6.29E-07; Z-score: -1.62E+00 | ||
Methylation in Case |
7.12E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg07520093) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.30E+00 | Statistic Test | p-value: 3.75E-05; Z-score: 7.74E-01 | ||
Methylation in Case |
6.19E-02 (Median) | Methylation in Control | 4.76E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of ABCC2 in hepatocellular carcinoma | [ 5 ] | |||
Location |
3'UTR (cg10841077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.40E-03; Z-score: -5.05E-01 | ||
Methylation in Case |
8.98E-01 (Median) | Methylation in Control | 9.07E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg05914069) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 7.08E-04; Z-score: -1.46E+00 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 8.57E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg16377144) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.75E-03; Z-score: -1.02E+00 | ||
Methylation in Case |
8.10E-01 (Median) | Methylation in Control | 8.37E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
TSS200 (cg09448875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.70E-02; Z-score: -6.37E-01 | ||
Methylation in Case |
9.44E-01 (Median) | Methylation in Control | 9.55E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg17044311) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 2.88E-23; Z-score: 3.42E+00 | ||
Methylation in Case |
8.68E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg14303526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 5.25E-22; Z-score: 3.19E+00 | ||
Methylation in Case |
8.63E-01 (Median) | Methylation in Control | 7.13E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg03381359) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 2.52E-18; Z-score: 3.77E+00 | ||
Methylation in Case |
8.95E-01 (Median) | Methylation in Control | 7.40E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg19604369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 3.99E-16; Z-score: 2.21E+00 | ||
Methylation in Case |
8.78E-01 (Median) | Methylation in Control | 7.90E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg19378330) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.77E+00 | Statistic Test | p-value: 5.17E-07; Z-score: 2.08E+00 | ||
Methylation in Case |
6.80E-02 (Median) | Methylation in Control | 3.85E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg02672229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.38E-05; Z-score: 6.75E-01 | ||
Methylation in Case |
7.69E-01 (Median) | Methylation in Control | 7.27E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg12673726) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.75E+00 | Statistic Test | p-value: 4.33E-05; Z-score: 2.23E+00 | ||
Methylation in Case |
5.89E-02 (Median) | Methylation in Control | 3.36E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
Body (cg05403832) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.05E-02; Z-score: -5.39E-01 | ||
Methylation in Case |
6.04E-01 (Median) | Methylation in Control | 6.25E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of ABCC2 in HIV infection | [ 6 ] | |||
Location |
3'UTR (cg10841077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 2.09E-04; Z-score: 8.29E-01 | ||
Methylation in Case |
9.45E-01 (Median) | Methylation in Control | 9.31E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg00826767) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.52E-03; Z-score: 1.22E+00 | ||
Methylation in Case |
8.42E-01 (Median) | Methylation in Control | 7.99E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg16377144) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 1.98E-02; Z-score: 1.32E+00 | ||
Methylation in Case |
7.81E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg08720365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.81E-05; Z-score: -2.85E+00 | ||
Methylation in Case |
7.92E-01 (Median) | Methylation in Control | 8.29E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg00706648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.88E-03; Z-score: -2.14E+00 | ||
Methylation in Case |
7.50E-01 (Median) | Methylation in Control | 7.90E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg05916255) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.54E-02; Z-score: -1.73E+00 | ||
Methylation in Case |
8.09E-01 (Median) | Methylation in Control | 8.36E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg13617376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.05E-02; Z-score: -1.69E+00 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
TSS1500 (cg05914069) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.54E-02; Z-score: -2.16E-01 | ||
Methylation in Case |
7.84E-01 (Median) | Methylation in Control | 7.90E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
TSS200 (cg09448875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 5.11E-03; Z-score: 7.78E-01 | ||
Methylation in Case |
9.14E-01 (Median) | Methylation in Control | 8.94E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg00706648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 5.10E-08; Z-score: -1.28E+00 | ||
Methylation in Case |
7.45E-01 (Median) | Methylation in Control | 7.64E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg03381359) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.04E-05; Z-score: -7.06E-01 | ||
Methylation in Case |
9.28E-01 (Median) | Methylation in Control | 9.38E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg14303526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 6.17E-05; Z-score: 7.22E-01 | ||
Methylation in Case |
8.58E-01 (Median) | Methylation in Control | 8.18E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg07520093) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 1.75E-03; Z-score: -5.30E-01 | ||
Methylation in Case |
3.86E-02 (Median) | Methylation in Control | 4.43E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg08720365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.24E-03; Z-score: -6.77E-01 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg25290633) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.49E-03; Z-score: -4.69E-01 | ||
Methylation in Case |
9.10E-01 (Median) | Methylation in Control | 9.19E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg13617376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.84E-03; Z-score: -4.76E-01 | ||
Methylation in Case |
9.11E-01 (Median) | Methylation in Control | 9.22E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in prostate cancer | [ 9 ] | |||
Location |
TSS1500 (cg07337598) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 2.65E-02; Z-score: 2.69E+00 | ||
Methylation in Case |
8.79E-01 (Median) | Methylation in Control | 8.51E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in prostate cancer | [ 9 ] | |||
Location |
3'UTR (cg07551022) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 4.47E-02; Z-score: 1.74E+00 | ||
Methylation in Case |
9.43E-01 (Median) | Methylation in Control | 9.20E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in systemic lupus erythematosus | [ 10 ] | |||
Location |
TSS1500 (cg16377144) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 9.52E-03; Z-score: -2.64E-01 | ||
Methylation in Case |
8.51E-01 (Median) | Methylation in Control | 8.59E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in systemic lupus erythematosus | [ 10 ] | |||
Location |
TSS1500 (cg05914069) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.41E-02; Z-score: -2.01E-01 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg05916255) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.47E-02; Z-score: -1.70E-01 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.39E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg02672229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.41E-02; Z-score: -4.79E-02 | ||
Methylation in Case |
7.58E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg00706648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 3.37E-05; Z-score: -1.13E+00 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 8.39E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg02672229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 1.99E-04; Z-score: -9.80E-01 | ||
Methylation in Case |
7.26E-01 (Median) | Methylation in Control | 7.95E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg03381359) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 2.97E-04; Z-score: 5.67E-01 | ||
Methylation in Case |
9.40E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg05403832) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.66E+00 | Statistic Test | p-value: 1.45E-03; Z-score: -8.63E-01 | ||
Methylation in Case |
1.53E-01 (Median) | Methylation in Control | 2.55E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg05916255) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.41E+00 | Statistic Test | p-value: 1.82E-03; Z-score: -4.43E-01 | ||
Methylation in Case |
4.40E-02 (Median) | Methylation in Control | 1.06E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg07520093) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 4.03E-03; Z-score: 1.98E-01 | ||
Methylation in Case |
3.25E-01 (Median) | Methylation in Control | 3.06E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg08720365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 7.81E-03; Z-score: 1.23E+00 | ||
Methylation in Case |
8.31E-01 (Median) | Methylation in Control | 7.25E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg12673726) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 2.86E-02; Z-score: 4.19E-01 | ||
Methylation in Case |
1.04E-01 (Median) | Methylation in Control | 9.91E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg13617376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 3.76E-02; Z-score: 7.52E-02 | ||
Methylation in Case |
1.14E-01 (Median) | Methylation in Control | 1.13E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg14303526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 4.45E-02; Z-score: 4.23E-01 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.28E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of ABCC2 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
3'UTR (cg10841077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 4.01E-12; Z-score: -4.80E+00 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 9.83E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCC2 in panic disorder | [ 12 ] | |||
Location |
Body (cg12673726) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.76E-01 | Statistic Test | p-value: 1.52E-02; Z-score: -4.21E-01 | ||
Methylation in Case |
-4.77E+00 (Median) | Methylation in Control | -4.65E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCC2 in panic disorder | [ 12 ] | |||
Location |
Body (cg03381359) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 1.92E-02; Z-score: -5.68E-01 | ||
Methylation in Case |
1.29E+00 (Median) | Methylation in Control | 1.51E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Liver cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant/significant hypermethylation of ABCC2 in liver cancer than that in healthy individual/adjacent tissue | ||||
Studied Phenotype |
Liver cancer [ICD-11:2C12] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.47E-09; Fold-change: -0.330225144; Z-score: -1.734613148 | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue |
p-value: 2.92E-10; Fold-change: -0.327111157; Z-score: -2.331280663 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of ABCC2 in melanocytoma than that in healthy individual | ||||
Studied Phenotype |
Melanocytoma [ICD-11:2F36.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.16E-11; Fold-change: -0.616986191; Z-score: -33.83827015 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of ABCC2 in melanoma than that in healthy individual | ||||
Studied Phenotype |
Melanoma [ICD-11:2C30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.22E-05; Fold-change: -0.430938666; Z-score: -16.04603395 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
microRNA |
|||||
Colorectal cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
High expression of miR-297 in colorectal cancer (compare to oxaliplatin-resistance counterpart cell) | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Luciferase reporter assay | ||
Related Molecular Changes |
Down regulation of ABCC2 | Experiment Method | RT-qPCR | ||
miRNA Stemloop ID |
miR-297 | miRNA Mature ID | miR-297 | ||
miRNA Sequence |
AUGUAUGUGUGCAUGUGCAUG | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples, Multiple cell lines of human | ||||
Additional Notes |
miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2. | ||||
Ovarian cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
High expression of miR-490-3p in ovarian cancer (compare to multidrug-resistance counterpart cell) | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Luciferase reporter assay | ||
Related Molecular Changes |
Down regulation of ABCC2 | Experiment Method | Immunohistochemical staining | ||
miRNA Stemloop ID |
miR-490 | miRNA Mature ID | miR-490-3p | ||
miRNA Sequence |
CAACCUGGAGGACUCCAUGCUG | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
Ovarian cancer [ ICD-11: 2C73] | ||||
Experimental Material |
Multiple cell lines of human | ||||
Additional Notes |
miR-490-3p overexpression may increase the sensitivity of ovarian cancer cells to cisplatin by targeting ABCC2. | ||||
Hepatocellular carcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Low expression of miR-379 in HCC (compare with rifampicin treatment counterpart cells) | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Luciferase reporter assay | ||
Related Molecular Changes |
Down regulation of ABCC2 | Experiment Method | Western Blot | ||
miRNA Stemloop ID |
miR-379 | miRNA Mature ID | miR-379-5p | ||
miRNA Sequence |
UGGUAGACUAUGGAACGUAGG | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Human hepatocellular carcinoma cells line (HepG2) | ||||
Additional Notes |
Down-regulation of ABCC2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379 | ||||
Chronic myeloid leukemia |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-205-5p downregulate ABCC2 expression | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Luciferase reporter assay | ||
Related Molecular Changes |
Down regulation of ABCC2 | Experiment Method | Western Blot | ||
miRNA Stemloop ID |
miR-205 | miRNA Mature ID | miR-205-5p | ||
miRNA Sequence |
UCCUUCAUUCCACCGGAGUCUG | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
Chronic myeloid leukemia [ ICD-11: 2B33.1] | ||||
Experimental Material |
Chronic myelocytic leukemia cell line (K562) | ||||
Additional Notes |
miR-205-5p overexpression may increase the sensitivity of chronic myeloid leukemia cells to imatinib by targeting ABCC2. | ||||
Unclear Phenotype |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-490 directly targets ABCC2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Immunohistochemistry//Luciferase reporter assay//qRT-PCR//Western blot | ||
miRNA Stemloop ID |
miR-490 | miRNA Mature ID | miR-490-3p | ||
miRNA Sequence |
CAACCUGGAGGACUCCAUGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.